Potential application of heat shock proteins as therapeutic targets in Parkinson's disease

Neurochem Int. 2023 Jan:162:105453. doi: 10.1016/j.neuint.2022.105453. Epub 2022 Nov 17.

Abstract

Parkinson's disease (PD) is a common chronic neurodegenerative disease, and the heat shock proteins (HSPs) are proved to be of great value for PD. In addition, HSPs can maintain protein homeostasis, degrade and inhibit protein aggregation by properly folding and activating intracellular proteins in PD. This study mainly summarizes the important roles of HSPs in PD and explores their feasibility as targets. We introduced the structural and functional characteristics of HSPs and the physiological functions of HSPs in PD. HSPs can protect neurons from damage by degrading aggregates with three mechanisms, including the aggregation and removing α-Synuclein (α-Syn) aggregates, promotion the autophagy of abnormal proteins, and inhibition the apoptosis of degenerated neurons. This study underscores the importance of HSPs as targets in PD and helps to expand new mechanisms in PD treatment strategies.

Keywords: Heat shock proteins; Oxidative stress; PROTAC; Parkinson's disease; α-Synuclein.

Publication types

  • Review

MeSH terms

  • Heat-Shock Proteins / metabolism
  • Humans
  • Neurodegenerative Diseases*
  • Neurons / metabolism
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / metabolism
  • Protein Aggregates
  • alpha-Synuclein / metabolism

Substances

  • Heat-Shock Proteins
  • alpha-Synuclein
  • Protein Aggregates